Monthly update of U.S. Food and Drug Administration (FDA) approvals impacting the workers' compensation industry. myMatrixx's report includes new drug and indication approvals, discontinuation and withdrawals, new dosages or formulations of existing products and newly available generics in the last 12 months.
Monthly Drug News
A generic version of Horizon Pharma’s Pennsaid® 2% (diclofenac sodium topical solution) is now available. Other topical products containing diclofenac are already available as generics, but Apotex Inc. is the first with the 2% solution.
Impact to Workers’ Comp
Topical diclofenac is a popular product in workers’ compensation, whether it is the 1% gel, 1.3% patch or solution (either 1.5% or 2%). In retail settings, Pennsaid 2% tends to be the most costly formulation, so its generic availability is a welcome addition.
For any questions about the use of Pennsaid, diclofenac, or other topical NSAIDs and potential relatedness to a claim, please consult with your myMatrixx pharmacist.